Skip to main content
SpringerLink
Log in

Place de la tomographie d'émission à positron en gastro-entérologie

Positron emission tomography: indications in gastroenterology

  • Published:
Acta Endoscopica

Conclusion

La TEP apparaît aujourd'hui comme une technique incontournable en cancérologie. Associée aux autres modalités d'imagerie, elle permet des bilans très précis dans la stadification initiale et les récurrences d'un grand nombre d'affections malignes. Sur le plan médico-économique, elle permettra probablement, comme le démontre un certain nombre de publications américaines, des économies substantielles obtenues essentiellement en évitant des chirurgies inutiles. En cas de chirurgie possible, on pourra utiliser des sondes per-opératoires dans le but d'obtenir une exérèse complète.

L'importance de la fixation du18FDG étant directement liée à l'évolutivité des lésions, la TEP apparaît également comme un excellent moyen de contrôle de l'efficacité d'une chimiothérapie et ceci dès la première ou deuxième cure [25].

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Références

  1. AKHURST T., LARSON S.M.—Positron emission tomography imaging of colorectal cancer.Semin. Oncol., 1999 Oct.,26 (5), 577–583.

    PubMed  CAS  Google Scholar 

  2. BENDER H., BANGARD N., METTEN N., BANGARD M., MEZGER J., SCHOMBURG A.—Possible role of FDG-PET in the early prediction of therapy outcome in liver metastases of colorectal cancer.Hybridoma, 1999 Feb.,18(1), 87–91.

    Article  PubMed  CAS  Google Scholar 

  3. BENYOUNES H., SMITH F.W., CAMPBELL C., EVANS N.T., NORTON M.Y., MIKECZ P., HEYS S.D., BRUCE D., EREMIN O., SHARP P.F.—Superimposition of PET images using 18F-fluorodeoxyglucose with magnetic resonance images in patients with pancreatic carcinoma.Nucl. Med. Commun., 1995 Jul.,16(7), 575–580.

    Article  PubMed  CAS  Google Scholar 

  4. BOYKIN K.N., ZIBARI G.B., LILIEN D.L., McMILLAN R.W., AULTMAN D.F., McDONALD J.C.—The use of FDG-positron emission tomography for the evaluation of colorectal metastases of the liver.Am. Surg., 1999 Dec.,65 (12), 1183–1185.

    PubMed  CAS  Google Scholar 

  5. COMBS C.S., BRUNT E.M., LOWE V.J., WOLVERSON M.K., SOLOMON H., COLLINS B.T., DI BISCEGLIE A.M. —Positron emission tomography scanning in the evaluation of hepatocellular carcinoma.J. Hepatol., 2000 May,32 (5), 792–797.

    Article  PubMed  Google Scholar 

  6. DELBEKE D., ROSE D.M., CHAPMAN W.C., PINSON C.W., WRIGHT J.K., BEAUCHAMP R.D., SHYR Y., LEACH S.D.—Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma.J. Nucl. Med., 1999 Nov,40(11), 1784–1791.

    PubMed  CAS  Google Scholar 

  7. DELBEKE D., MARTIN W.H., SANDLER M.P., CHAPMAN W.C., WRIGHT J.K.J.R., PINSON C.W.—Evaluation of benign vs malignant hepatic lesions with positron emission tomography.Arch. Surg. 1998 May,133 (5), 510–515; discussion, 510–516.

    Article  PubMed  CAS  Google Scholar 

  8. FLAMEN P., STROOBANTS S., VAN CUTSEM E., DUPONT P., BORMANS G., DE VADDER N., PENNINCKX F., VAN HOE L., MORTELMANS L.—Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose in recurrent colorectal cancer.J. Clin. Oncol., 1999 Mar,17(3), 894–901.

    PubMed  CAS  Google Scholar 

  9. FLANAGAN F.L., DEHDASHTI F., SIEGEL B.A., TRASK D.D., SUNDARESAN S.R., PATTERSON G.A., COOPER J.D.—Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography.AJR Am. J. Roentgenol., 1997 Feb.,168(2), 417–424.

    PubMed  CAS  Google Scholar 

  10. FONG Y., SALDINGER P.F., AKHURST T., MACAPINLAC H., YEUNG H., FINN R.D., COHEN A., KEMENY N., BLUMGART L.H., LARSON S.M.—Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases.Am. J. Surg., 1999 Oct.,178(4), 282–287.

    Article  PubMed  CAS  Google Scholar 

  11. FRANKE C., KLAPDOR R., MEYERHOFF K., SCHAUMAN M. —18-FDG positron emission tomography of the pancreas: diagnostic benefit in the follow-up of pancreatic carcinoma.Anticancer Res., 1999 Jul.–Aug.,19(4A), 2437–2442.

    PubMed  CAS  Google Scholar 

  12. HO C.L., DEHDASHTI F., GRIFFETH L.K., BUSE P.E., BALFE D.M., SIEGEL B.A.—FDG-PET evaluation of indeterminate pancreatic masses.J. Comput. Assist. Tomogr., 1996 May–Jun,20(3), 363–369.

    Article  PubMed  CAS  Google Scholar 

  13. HUSTINX R., PAULUS P., DAENEN F., DETROZ B., HONORE P., JACQUET N., RIGO P.—Role of positron emission tomography is the evaluation of digestive tract tumors.Rev. Med. Liege, 1999 Dec.,54(12), 925–930.

    PubMed  CAS  Google Scholar 

  14. GUPTA N., BRADFIELD H.—Role of positron emission tomography scanning in evaluating gastrointestinal neoplasms.Semin. Nucl. Med., 1996 Jan.,26(1), 65–73.

    Article  PubMed  CAS  Google Scholar 

  15. IMDAHL A., REINHARDT M.J., NITZSCHE E.U., MIX M., DINGELDEY A., EINERT A., BAIER P., FARTHMANN E.H.—Impact of 18F-FDG-positron emission tomography for decision making in colorectal cancer recurrences.Langenbecks Arch. Surg., 2000 Mar,385(2), 129–134

    Article  PubMed  CAS  Google Scholar 

  16. INOKUMA T., TAMAKI N., TORIZUKA T., MAGATA Y., FUJII M., YONEKURA Y., KAJIYAMA T., OHSHIO G., IMAMURA M., KONISHI—Evaluation of pancreatic tumors with positron emission tomography and F-18 fluorodeoxyglucose: comparison with CT and US.J. Radiology, 1995 May,195(2), 345–352.

    CAS  Google Scholar 

  17. IWATA Y., SHIOMI S., SASAKI N., JOMURA H., NISHIGUCHI S., SEKI S., KAWABE J., OCHI H.—Clinical usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in the diagnosis of liver tumors.Ann. Nucl. Med., 2000 Apr,14(2), 121–126.

    Article  PubMed  CAS  Google Scholar 

  18. KOLE A.C., PLUKKER J.T., NIEWEG O.E.—Positron emission tomography for staging of oesophageal and gastroesophageal malignancy.Br. J. Cancer, 1998 Aug.,78(4), 521–527.

    PubMed  CAS  Google Scholar 

  19. LANDONI C., GIANOLLI L., LUCIGNANI G., MAGNANI P., SAVI A., TRAVAINI L., GILARDI M.C., FAZIO F.— Comparison of dual-head coincidence PET versus ring PET in tumor patients.J. Nucl. Med., 1999 Oct,40(10), 1617–1622.

    PubMed  CAS  Google Scholar 

  20. LONNEUX M., SIBOMANA M., PAUWELS S., GREGOIRE V. —Current data and perspectives on positron emission tomography oncology-radiotherapy.Cancer Radiother., 1999 Jul.–Aug.,3(4), 275–288.

    PubMed  CAS  Google Scholar 

  21. PHELPS M.E.—PET: the merging of biology and imaging into molecular imaging.J. Nucl. Med., 2000 Aprl.,41(4), 661–681.

    PubMed  CAS  Google Scholar 

  22. RANKIN S.C., TAYLOR H., COOK G.J., MASON R.— Computed tomography and positron emission tomography in the pre-operative staging of oesophageal carcinoma.Clin. Radiol., 1998 Sep.,53(9), 659–665.

    Article  PubMed  CAS  Google Scholar 

  23. RESKE S.N., GRILLENBERGER K.G., GLATTING G., PORT M., HILDEBRANDT M., GANSAUGE F., BEGER H.G.—Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma.J. Nucl. Med., 1997 Sep.,38(9), 1344–1348.

    PubMed  CAS  Google Scholar 

  24. SCHRODER O., TROJAN J., ZEUZEM S., BAUM R.P.— Limited value of fluorine-18-fluorodeoxyglucose PET for the differential diagnosis of focal liver lesions in patients with chronic hepatitis C virus infection.Nuklearmedizin, 1998,37 (8), 279–285.

    PubMed  CAS  Google Scholar 

  25. STRAUSS L.G.—Positron Emission Tomography: Current Role for Diagnosis and Therapy Monitoring in Oncology.Oncologist, 1997,2(6), 381–388.

    PubMed  Google Scholar 

  26. TORIZUKA T., TAMAKI N., INOKUMA T., MAGATA Y., SASAYAMA S., YONEKURA Y., TANAKA A., YAMAOKA Y., YAMAMOTO K., KONISHI J.—In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET.J. Nucl. Med., 1995 Oct,36(10), 1811–1817.

    PubMed  CAS  Google Scholar 

  27. TORIZUKA T., TAMAKI N., INOKUMA T., MAGATA Y., YONEKURA Y., TANAKA A., YAMAOKA Y., YAMAMOTO K., KONISHI J.—Value of fluorine-18-FDG-PET to monitor hepatocellular carcinoma after interventional therapy.J. Nucl. Med., 1994 Dec.,35(12), 1965–1969.

    PubMed  CAS  Google Scholar 

  28. TROJAN J., SCHROEDER O., RAEDLE J., BAUM R.P., HERRMANN G., JACOBI V., ZEUZEM S.—Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma.Am. J. Gastroenterol., 1999 Nov,94(11), 3314–3319.

    Article  PubMed  CAS  Google Scholar 

  29. ZIMNY M., BARES R., FASS J., ADAM G., CREMERIUS U., DOHMEN B., KLEVER P., SABRI O., SCHUMPELICK V., BUELL U.—Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases.Eur. J. Nucl. Med., 1997 Jun,24(6), 678–682.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service de Médecine Nucléaire, Centre Hospitalier Universitaire, 87042, Limoges Cedex, (France)

    R. Perdrisot & J. C. Vandroux

  2. Service d'Hépato-Gastro-Entérologie, Centre Hospitalier Universitaire, 87042, Limoges Cedex, (France)

    J. Monteil, S. Verbeke, T. Ducloux & D. Sautereau

  3. Service de Chirurgie Endocrinienne, Digestive et Générale, Centre Hospitalier Universitaire, 87042, Limoges Cedex, (France)

    A. Gainant

  4. Service de Chirurgie Viscérale et Transplantations, Centre Hospitalier Universitaire, 87042, Limoges Cedex, (France)

    B. Descottes

Authors
  1. J. Monteil
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Verbeke
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Ducloux
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Sautereau
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Gainant
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. B. Descottes
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. R. Perdrisot
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. J. C. Vandroux
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Monteil, J., Verbeke, S., Ducloux, T. et al. Place de la tomographie d'émission à positron en gastro-entérologie. Acta Endosc 30 (Suppl 2), 377–381 (2000). https://doi.org/10.1007/BF03017982

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03017982

Mots-clés

Key-words

Search

Navigation